Serum CEA levels can predict the prognosis and recurrence of colorectal cancer, and the later the disease stage is, the higher serum CEA levels are, and increased CEA is correlated with poor tumor differentiation (40–42). The gene discussed is CEACAM5; the disease is neoplasm.